Novozymes announce the Executive Leadership Team and organizational structure for the future combined company of Novozymes and Chr. HansenGlobeNewsWire • 10/10/23
Executive Leadership Team and organizational structure announced for the future combined company of Novozymes and Chr. HansenGlobeNewsWire • 10/10/23
Novozymes launches new biosolution to redefine the plant-based meat experience by enhancing texture and encouraging more consumers to choose plant-based alternativesGlobeNewsWire • 09/28/23
Update on the combination of Novozymes and Chr. Hansen: Chinese merger approval granted, supporting the path to completionGlobeNewsWire • 09/04/23
Novozymes and Bactolife join forces to significantly reduce post weaning diarrhea and antibiotic use among weaner pigsGlobeNewsWire • 09/04/23
Novozymes delivers results within expectations in the first half of 2023 and narrows the full year outlookGlobeNewsWire • 08/09/23
Novozymes' and Chr. Hansen's shareholders approve combination to create a leading global biosolutions partnerGlobeNewsWire • 03/30/23
Resolutions from Novozymes A/S' Extraordinary Shareholders' Meeting on 30 March 2023GlobeNewsWire • 03/30/23
Combination between Novozymes and Chr. Hansen approved by the Novozymes shareholdersGlobeNewsWire • 03/30/23
Update on the combination of Novozymes and Chr. Hansen: U.S. antitrust regulation waiting period has expired, supporting the path to completionGlobeNewsWire • 03/28/23
Publication of exemption document in relation to the proposed combination of Novozymes and Chr. Hansen, confirmation of outlook for 2023 and proposed candidates to the Board of Directors of the combined companyGlobeNewsWire • 03/08/23